Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

UBS gains on report of it mulling ways to avoid Swiss bank rules

The lender’s discussions involve possibly combining with a foreign bank

The Swiss bank UBS has seen its share price rise following a report that the company is considering ways to evade stricter capital rules imposed by Swiss regulators. Morgan Stanley, Deutsche Bank, and Standard Chartered, among other banks, were mentioned as potential foreign counterparts for a combination deal to help UBS bypass the new regulations.

UBS has reportedly revived discussions about moving its operations out of Switzerland, in response to a proposal from a majority of the Upper House of Switzerland's parliament. The Upper House urged the bank to hold an additional $16 billion in CET1 capital, while the Lower House is expected to deliberate on the matter next. A final decision on the plan is not anticipated until sometime in 2027.

UBS shares surged 2.5 percent in early trading in Zurich on Friday, while Deutsche Bank and Standard Chartered also gained. In contrast, Morgan Stanley's shares dropped by 1 percent in New York trading on Thursday.

Written by urgent.news from The Business Times - Companies & Markets's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at businesstimes.com.sg →

More in Finance & Markets

CVC, NSSK weigh $3.2bn Kobayashi Pharmaceutical take-private

PE firm CVC Capital Partners and Japanese investment firm Nippon Sangyo Suishin Kiko (NSSK) are considering a bid of more than JPY500bn ($3.2bn) to take Japanese healthcare products company Kobayashi…

  • CVC Capital Partners and NSSK consider $3.2bn joint bid for Kobayashi Pharmaceutical.
  • Takeover aims to privatize company amid red yeast supplement controversy.
  • Oasis Management and Kobayashi family hold significant stakes in the firm.

More from Friday 25 September →